Population-level identification of patients with MMR mutation-positive endometrial cancer is optimized by stepwise testing for tumor MMR IHC loss in patients younger than 60 years, tumor MLH1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback